Essential role for proteinase-activated receptor-2 in arthritis

Journal of Clinical Investigation

Volumn 111, Issue 1, 2003, Pages 35-41

  Ferrell, William R ^a,g   Lockhart, John C ^b   Kelso, Elizabeth B ^a   Dunning, Lynette ^b   Plevin, Robin ^c   Meek, Stephen E ^d   Smith, Andrew J H ^d   Hunter, Gary D ^c   McLean, John S ^b   McGarry, Frances ^b   Ramage, Robert ^e   Jiang, Lu ^e   Kanke, Toru ^f   Kawagoe, Junichi ^f  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b UNIVERSITY OF THE WEST OF SCOTLAND   (United Kingdom)

^c UNIVERSITY OF STRATHCLYDE   (United Kingdom)

^d UNIVERSITY OF EDINBURGH   (United Kingdom)

^e Albachem Limited   (United Kingdom)

^f Kowa Company Limited   (Japan)

^g GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; ASKH 115; ASKH 95; PROTEINASE ACTIVATED RECEPTOR 2; UNCLASSIFIED DRUG;

ANIMAL MODEL; ARTERIOLE; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENDOTHELIUM CELL; GENE ACTIVATION; GENE DISRUPTION; GENE EXPRESSION; HETEROZYGOSITY; HISTOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; STRUCTURE ANALYSIS; SYNOVIUM; UPREGULATION;

EID: 0037247658     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI16913     Document Type: Article

References (22)

1. Steinhoff, M., et al. 2000. Agonists of proteinase-activated receptor-2 induce inflammation by a neurogenic mechanism. Nat. Med. 6:151-158.
2. Vergnolle, N., et al. 2001. Proteinase-activated receptor-2 and hyperalgesia: a novel pain pathway. Nat. Med. 7:821-826.
3. Damiano, B.P., D'Andrea, M.R., de Garavilla, L., Cheung, W.M., and Andrade-Gordon, P. 1999. Increased expression of protease activated receptor-2 (PAR2) in balloon-injured rat carotid artery. Thromb. Haemost. 81:808-814.
4. Nehls, M., et al. 1996. Two genetically separable steps in the differentiation of thymic epithelium. Science. 272:886-889.
5. Smith, A.G. 1991. Culture and differentiation of embryonic stem cells. J. Tissue Cult. Methods. 13:89-94.
6. Bradley, A. 1987. Production and analysis of chimaeric mice. In Teratocarcinoma and embryo derived stem cells: a practical approach. E.J. Robertson, editor. IRL Press. Oxford, United Kingdom. 113-151.
7. Bertog, M., et al. 1999. Basolateral proteinase-activated receptor (PAR-2) induces chloride secretion in M-1 mouse renal cortical collecting duct cells. J. Physiol. 521:3-17.
8. Mountford, P., et al. 1994. Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression. Proc. Natl. Acad. Sci. USA. 91:4303-4307.
9. Blackhart, B.D., et al. 1996. Ligand cross-reactivity within the protease-activated receptor family. J. Biol. Chem. 271:16466-16471.
10. Maryanoff, B.E., et al. 2001. Protease-activated receptor-2 (PAP-2): structure-function study of receptor activation by diverse peptides related to tethered-ligand epitopes. Arch. Biochem. Biophys. 386:195-204.
11. Kanke, T., et al. 2001. Proteinase-activated receptor-2-mediated activation of stress-activated protein kinases and inhibitory ΚB kinases in NCTC 2544 keratinocytes. J. Biol. Chem. 276:31657-31666.
12. Plevin, R., Kellock, N.A., Wakelam, M.J.O., and Wadsworth, R. 1994. Regulation by hypoxia of endothelin-1-stimulated phospholipase D activity in sheep pulmonary artery cultured smooth muscle cells. Br. J. Pharmacol. 112:311-315.
13. Ramage, R., et al. 1999. Comparative studies of Nsc and Fmoc as N (alpha)-protecting groups for SPPS. J. Pept. Sci. 5:195-200.
14. Lam, F.Y., and Ferrell, W.R. 1993. Acute inflammation in the rat knee joint attenuates sympathetic vasoconstriction but enhances neuropeptide-mediated vasodilatation assessed by laser Doppler perfusion imaging. Neuroscience. 52:443-449.
15. Damiano, B.P., et al. 1999. Cardiovascular responses mediated by protease-activated receptor-2 (PAR-2) and thrombin receptor (PAR-1) are distinguished in mice deficient in PAR-2 or PAR-1. J. Pharmacol. Exp. Ther. 288:671-678.
16. 2)-activating peptides in the rat paw. Br. J. Pharmacol. 127:1083-1090.
17. Berger, J., Hauber, J., Hauber, R., Geiger, R., and Cullen, B.R. 1988. Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene. 66:1-10.
18. Yang, Y., Loy, J., Ryseck, R.P., Carrasco, D., and Bravo, R. 1998. Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood. 92:3912-3923.
19. Lindner, J.R., et al. 2000. Delayed onset of inflammation in protease-activated receptor-2-deficient mice. J. Immunol. 165:6504-6510.
20. De Felipe, C., et al. 1998. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:394-397.
21. Shpacovitch, V.M., et al. 2002. Agonists of proteinase-activated receptor 2 induce cytokine release and activation of nuclear transcription factor kappaB in human dermal microvascular endothelial cells. J. Invest. Dermatol. 118:380-385.
22. Asokananthan, N., et al. 2002. Activation of protease-activated receptor (PAR)-1, PAR-2 and PAR-4 stimulate IL-6, IL-8 and prostaglandin E(2) release from human respiratory epithelial cells. J. Immunol. 168:3577-3585.